Save on Acid Reflux Medications in Texas
Compare Acid Reflux Medications prices across Texas pharmacies. Save up to 64% — no insurance required.
Top Acid Reflux Medications for Texas Residents
Omeprazole (Prilosec)
Pantoprazole (Protonix)
Esomeprazole (Nexium)
Dexlansoprazole (Dexilant)
Famotidine (Pepcid)
Texas Prescription Assistance Programs
CHIP (Children's Health Insurance Program)
Prescription drug coverage for uninsured Texas children in families with incomes too high for Medicaid but unable to afford private insurance.
Eligibility: Texas children aged 0–18 in families with income up to 201% FPL not eligible for Medicaid. Call 1-877-KIDS-NOW (1-877-543-7669).
Texas Medicaid Rx (STAR Program)
Prescription drug coverage for Texas Medicaid (STAR managed care) beneficiaries.
Eligibility: Low-income Texas children, pregnant women, people with disabilities, and some seniors. Texas has not expanded Medicaid to full ACA adult coverage.
Frequently Asked Questions
Is omeprazole cheap as a generic?
Generic omeprazole is available OTC for around $10–$15/month and prescription generics are even cheaper per-unit via ScriptUnlock bids — often under $10 for a 30-day supply.
Should I use a PPI or H2 blocker for acid reflux?
PPIs are more potent and appropriate for GERD; H2 blockers like famotidine work well for occasional reflux. Your doctor or pharmacist can guide the choice — ScriptUnlock helps with pricing for either.
How much can I save switching from Nexium to esomeprazole?
Brand Nexium can cost $200–$300/month without insurance; generic esomeprazole is typically $20–$40. ScriptUnlock bids make that comparison instant and actionable.
Can I use ScriptUnlock for compounded omeprazole suspension?
Yes. Compounded omeprazole for pediatric or NG-tube patients can be sourced through ScriptUnlock compounding pharmacy partners.
Is long-term PPI use safe?
PPIs are generally safe for appropriate indications but should be used at the lowest effective dose. Discuss duration and tapering with your prescriber — ScriptUnlock helps with the cost, not the clinical decision.